AU3124300A - Inhibitors of beta-lactamases and uses therefor - Google Patents

Inhibitors of beta-lactamases and uses therefor

Info

Publication number
AU3124300A
AU3124300A AU31243/00A AU3124300A AU3124300A AU 3124300 A AU3124300 A AU 3124300A AU 31243/00 A AU31243/00 A AU 31243/00A AU 3124300 A AU3124300 A AU 3124300A AU 3124300 A AU3124300 A AU 3124300A
Authority
AU
Australia
Prior art keywords
lactamases
inhibitors
beta
uses therefor
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31243/00A
Inventor
Maria Paola Costi
Brian K. Shoichet
Donatella Tondi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universita' Degli Studi di Modena e Reggio Emilia
Northwestern University
Original Assignee
UNI DEGLI STUDI DI MODENA E RE
Universita' Degli Studi di Modena e Reggio Emilia
Northwestern University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UNI DEGLI STUDI DI MODENA E RE, Universita' Degli Studi di Modena e Reggio Emilia, Northwestern University filed Critical UNI DEGLI STUDI DI MODENA E RE
Publication of AU3124300A publication Critical patent/AU3124300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System
    • C07F5/02—Boron compounds
    • C07F5/025—Boronic and borinic acid compounds
AU31243/00A 1998-12-16 1999-12-16 Inhibitors of beta-lactamases and uses therefor Abandoned AU3124300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11244898P 1998-12-16 1998-12-16
US60112448 1998-12-16
PCT/US1999/029958 WO2000035904A1 (en) 1998-12-16 1999-12-16 INHIBITORS OF β-LACTAMASES AND USES THEREFOR

Publications (1)

Publication Number Publication Date
AU3124300A true AU3124300A (en) 2000-07-03

Family

ID=22343962

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31243/00A Abandoned AU3124300A (en) 1998-12-16 1999-12-16 Inhibitors of beta-lactamases and uses therefor

Country Status (2)

Country Link
AU (1) AU3124300A (en)
WO (1) WO2000035904A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858592B2 (en) 2001-06-29 2005-02-22 Genzyme Corporation Aryl boronic acids for treating obesity
US7041280B2 (en) 2001-06-29 2006-05-09 Genzyme Corporation Aryl boronate functionalized polymers for treating obesity
US7112572B2 (en) 2002-09-09 2006-09-26 Trigen Limited Multivalent metal salts of boronic acids
PT2603514T (en) 2010-08-10 2018-11-09 Rempex Pharmaceuticals Inc Cyclic boronic acid ester derivatives and therapeutic uses thereof
US9012491B2 (en) 2011-08-31 2015-04-21 Rempex Pharmaceuticals, Inc. Heterocyclic boronic acid ester derivatives and therapeutic uses thereof
US9156858B2 (en) 2012-05-23 2015-10-13 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US10561675B2 (en) 2012-06-06 2020-02-18 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
AU2014204045B2 (en) 2013-01-04 2018-10-18 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US9101638B2 (en) 2013-01-04 2015-08-11 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
CA2894892A1 (en) 2013-01-04 2014-07-10 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
US9241947B2 (en) 2013-01-04 2016-01-26 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
LT3604316T (en) 2014-05-05 2024-02-26 Melinta Therapeutics, Inc. Synthesis of boronate salts
WO2015171398A1 (en) 2014-05-05 2015-11-12 Rempex Pharmaceuticals, Inc. Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof
WO2015179308A1 (en) 2014-05-19 2015-11-26 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2016003929A1 (en) 2014-07-01 2016-01-07 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
WO2016081297A1 (en) 2014-11-18 2016-05-26 Rempex Pharmaceuticals, Inc. Cyclic boronic acid ester derivatives and therapeutic uses thereof
US20180051041A1 (en) 2015-03-17 2018-02-22 Rempex Pharmaceuticals, Inc. Boronic acid derivatives and therapeutic uses thereof
DK3478693T3 (en) 2016-06-30 2021-09-20 Qpex Biopharma Inc BORONIC ACID DERIVATIVES AND THERAPEUTIC USES THEREOF
US11286270B2 (en) 2017-10-11 2022-03-29 Qpex Biopharma, Inc. Boronic acid derivatives and synthesis thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612378A (en) * 1995-06-06 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Bis-arylsulfonylaminobenzamide derivatives and the use thereof as factor Xa inhibitors
US6008377A (en) * 1996-03-19 1999-12-28 Eli Lilly And Company Synthesis of 3-[4-(2-aminoethoxy)-benzoyl]-2-aryl-6-hydroxy-benzo[B]thiophenes

Also Published As

Publication number Publication date
WO2000035904A1 (en) 2000-06-22

Similar Documents

Publication Publication Date Title
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
AU4429799A (en) Inhibitors of p38
AU4231197A (en) Hppd gene and inhibitors
AU3109099A (en) Allosteric inhibitors and activators of pyruvate kinase
AU3665199A (en) Inhibitors of impdh enzyme
AU3972697A (en) Inhibitors of cysteine protease
AU1271297A (en) Inhibitor of ceramidase
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
PL334846A1 (en) Sulphamidic inhibitors of metaloproteases
AU1536799A (en) Bishydroxyureas as inhibitors of the 5-lipoxygenase
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
AU5619400A (en) Statine-derived tetrapeptide inhibitors of beta-secretase
AU3107795A (en) Inhibitors of the benzamidine type
AU9059798A (en) Urokinase inhibitors
AU5599598A (en) Inhibitors of glycosyltransferases
AU5463099A (en) Inhibitors of redox signaling and methods of using same
HUP0101640A3 (en) Certain thoil inhibitors of endothelin-converting enzyme
AU1969800A (en) Combination of active agents
AU2277597A (en) New inhibitors of sh2-mediated processes
AU9624398A (en) Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
AU1766997A (en) Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors
AU4501199A (en) 8-phenylxanthine derivatives and their use as phosphodiesterase inhibitors
AU1287100A (en) Peptide inhibitor of browman-birk type
AU2849399A (en) Monobactam enzyme inhibitors
AU2333099A (en) Aryloxyanilides and related compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase